BR112020006710A2 - Enantiômeros de tiazóis substituídos como compostos antivirais - Google Patents
Enantiômeros de tiazóis substituídos como compostos antiviraisInfo
- Publication number
- BR112020006710A2 BR112020006710A2 BR112020006710A BR112020006710A BR112020006710A2 BR 112020006710 A2 BR112020006710 A2 BR 112020006710A2 BR 112020006710 A BR112020006710 A BR 112020006710A BR 112020006710 A BR112020006710 A BR 112020006710A BR 112020006710 A2 BR112020006710 A2 BR 112020006710A2
- Authority
- BR
- Brazil
- Prior art keywords
- enantiomers
- antiviral compounds
- substituted thiazol
- antiviral
- medicaments
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/54—Nitrogen and either oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Abstract
ENANTIÔMEROS DE TIAZÓIS SUBSTITUÍDOS COMO COMPOSTOS ANTIVIRAIS. A presente invenção se refere a novos compostos antivirais com estereoconfiguração específica, especialmente a novos enantiômeros específicos, a um processo para a sua preparação e ao seu uso como medicamentos, em particular, como medicamentos antivirais.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP17195047 | 2017-10-05 | ||
PCT/EP2018/077022 WO2019068817A1 (en) | 2017-10-05 | 2018-10-04 | SUBSTITUTED THIAZOLEAN ENANTIOMERS AS ANTIVIRAL COMPOUNDS |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112020006710A2 true BR112020006710A2 (pt) | 2022-11-08 |
Family
ID=60022026
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112020006710A BR112020006710A2 (pt) | 2017-10-05 | 2018-10-04 | Enantiômeros de tiazóis substituídos como compostos antivirais |
Country Status (36)
Country | Link |
---|---|
US (2) | US11278534B2 (pt) |
EP (2) | EP4209491A1 (pt) |
JP (1) | JP7215689B2 (pt) |
KR (1) | KR20200066619A (pt) |
CN (1) | CN111433203B (pt) |
AR (1) | AR113344A1 (pt) |
AU (1) | AU2018344471B2 (pt) |
BR (1) | BR112020006710A2 (pt) |
CA (1) | CA3077397A1 (pt) |
CL (1) | CL2020000869A1 (pt) |
CR (1) | CR20200154A (pt) |
DK (1) | DK3692039T3 (pt) |
EA (1) | EA202090620A1 (pt) |
EC (1) | ECSP20021132A (pt) |
ES (1) | ES2939652T3 (pt) |
FI (1) | FI3692039T3 (pt) |
HR (1) | HRP20230158T1 (pt) |
HU (1) | HUE061307T2 (pt) |
IL (1) | IL273681A (pt) |
JO (1) | JOP20200110A1 (pt) |
LT (1) | LT3692039T (pt) |
MA (1) | MA50609B1 (pt) |
MD (1) | MD3692039T2 (pt) |
MX (1) | MX2020003369A (pt) |
NI (1) | NI202000025A (pt) |
PH (1) | PH12020550132A1 (pt) |
PL (1) | PL3692039T3 (pt) |
PT (1) | PT3692039T (pt) |
RS (1) | RS64000B1 (pt) |
SG (1) | SG11202002420SA (pt) |
SI (1) | SI3692039T1 (pt) |
TW (1) | TWI706941B (pt) |
UA (1) | UA126163C2 (pt) |
UY (1) | UY37917A (pt) |
WO (1) | WO2019068817A1 (pt) |
ZA (1) | ZA202002150B (pt) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111433203B (zh) * | 2017-10-05 | 2024-02-13 | 创新分子股份有限公司 | 作为抗病毒化合物的取代噻唑的对映异构体 |
WO2019168874A1 (en) | 2018-02-27 | 2019-09-06 | The Research Foundation For The State University Of New York | Difluoromethoxylation and trifluoromethoxylation compositions and methods for synthesizing same |
TW202038947A (zh) | 2018-11-28 | 2020-11-01 | 德商創新分子有限責任公司 | 在與溶瘤病毒之組合療法中治療癌症的解旋酶引子酶抑制劑 |
JP2023552274A (ja) | 2020-10-29 | 2023-12-15 | イノベーティブ モレキュールズ ゲーエムベーハー | 抗ウイルス化合物としての重水素化アミノチアゾール化合物 |
WO2023135303A1 (en) | 2022-01-17 | 2023-07-20 | Innovative Molecules Gmbh | Solid crystalline forms of helicase-primase inhibitors and process of preparation thereof |
WO2024049760A1 (en) | 2022-08-29 | 2024-03-07 | Assembly Biosciences, Inc. | Cyclic urea thiazolyl compounds for treatment of hsv |
WO2024047508A1 (en) | 2022-08-29 | 2024-03-07 | Assembly Biosciences, Inc. | Pharmaceutical compositions for herpes virus |
Family Cites Families (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH564301A5 (pt) | 1970-01-16 | 1975-07-31 | Shell Int Research | |
WO1997024343A1 (en) | 1995-12-29 | 1997-07-10 | Boehringer Ingelheim Pharmaceuticals, Inc. | Phenyl thiazole derivatives with anti herpes virus properties |
US6040321A (en) * | 1997-11-12 | 2000-03-21 | Bristol-Myers Squibb Company | Aminothiazole inhibitors of cyclin dependent kinases |
AU3289299A (en) | 1998-02-19 | 1999-09-06 | Tularik Inc. | Antiviral agents |
ATE229945T1 (de) | 1998-03-19 | 2003-01-15 | Upjohn Co | Zur behandlung von cmv infektionen geeignete 1,3, 4-thiadiazole |
DE19959958A1 (de) | 1999-12-13 | 2001-08-30 | Bayer Ag | Thiazolylharnstoff-Derivate |
US6500817B1 (en) | 1999-03-08 | 2002-12-31 | Bayer Aktiengesellschaft | Thiazolyl urea derivatives and their utilization as antiviral agents |
DE19927415A1 (de) | 1999-06-16 | 2000-12-21 | Bayer Ag | Indolinylharnstoffderivate |
DOP2000000109A (es) | 1999-12-23 | 2002-08-30 | Gerald Kleymann | Derivados de tiazolilamida |
DE10039265A1 (de) | 2000-08-11 | 2002-02-21 | Bayer Ag | Thiazolylamid-Derivate |
EP1319185A1 (en) | 2000-06-15 | 2003-06-18 | Bayer Aktiengesellschaft | Method for identifying compounds with anti-herpes activity |
DE10038022A1 (de) | 2000-08-04 | 2002-02-14 | Bayer Ag | Inverse Thiazolylamid-Derivate |
DE10044358A1 (de) | 2000-09-07 | 2002-03-21 | Bayer Ag | Thiazolylcarbonylheterocyclyl-Derivate |
DE10044328A1 (de) | 2000-09-07 | 2002-03-21 | Bayer Ag | Thiazolylcarbonyl-Derivate |
DE10044353A1 (de) | 2000-09-07 | 2002-04-04 | Bayer Ag | Unkompetitive Inhibitoren der Helikase-Primase |
DE10129717A1 (de) | 2001-06-22 | 2003-01-02 | Bayer Ag | Kombinationspräparate zur Herpes-Behandlung |
DE10129714A1 (de) | 2001-06-22 | 2003-01-02 | Bayer Ag | Topische Anwendung von Thiazolylamiden |
DE10129715A1 (de) | 2001-06-22 | 2003-01-02 | Bayer Ag | Thiazolylamide |
DE10129716A1 (de) | 2001-06-22 | 2003-01-02 | Bayer Ag | Kombinationspräparate zur Herpes-Behandlung |
DE10131128A1 (de) | 2001-06-28 | 2003-01-16 | Bayer Ag | Sekundäre Sulfonamide |
DE10210319A1 (de) | 2002-03-08 | 2003-09-18 | Bayer Ag | Thiazolylcarbonyl-Derivate |
DE10235967B4 (de) | 2002-08-06 | 2005-09-08 | Bayer Healthcare Ag | Methode zum Identifizieren von Substanzen mit antimikrobieller Wirkung |
DE10300109A1 (de) | 2003-01-07 | 2004-07-15 | Bayer Healthcare Ag | Methode zur Inhibition der Replikation von Herpesviren |
AU2005210474B2 (en) | 2004-01-30 | 2011-07-07 | Vertex Pharmaceuticals Incorporated | Modulators of ATP-Binding cassette transporters |
DE102005014248A1 (de) | 2005-03-30 | 2006-10-05 | Aicuris Gmbh & Co. Kg | Pharmazeutische Zubereitung von N-[5-(Aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamid |
US8548554B2 (en) | 2006-12-08 | 2013-10-01 | Fraunhofer-Gesellschaft Zur Forderung Der Angewandten Forschung E.V. | Dry electrode cap for electro-encephalography |
DE102010046720A1 (de) | 2010-09-23 | 2012-03-29 | Bayer Schering Pharma Aktiengesellschaft | Verfahren zur Herstellung von pan-CDK-Inhibitoren der Formel (l), sowie Intermediate der Herstellung |
JP5837936B2 (ja) * | 2010-11-01 | 2015-12-24 | ロマーク ラボラトリース,エル.シー. | アルキルスルフィニル置換チアゾリド化合物 |
TWI555737B (zh) | 2011-05-24 | 2016-11-01 | 拜耳知識產權公司 | 含有硫醯亞胺基團之4-芳基-n-苯基-1,3,5-三氮雜苯-2-胺 |
EP2573086A1 (en) | 2011-09-26 | 2013-03-27 | AiCuris GmbH & Co. KG | N-[5-(Aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mesylate monohydrate |
EP3440063B1 (en) * | 2016-04-06 | 2020-08-05 | Innovative Molecules GmbH | Aminothiazole derivatives useful as antiviral agents |
CN110062755B (zh) | 2016-11-28 | 2023-08-29 | 艾库里斯有限及两合公司 | 普瑞利韦的游离碱的马来酸盐、其药物制剂、其制造方法及其用于治疗疱疹病毒的用途 |
AR110250A1 (es) | 2016-11-28 | 2019-03-13 | Aicuris Anti Infective Cures Gmbh | Formulación tópica que comprende n-[5-(aminosulfonil)-4-metil-1,3-tiazol-2-il]-n-metil-2-[4-(2-piridinil)-fenil]-acetamida |
RS61905B1 (sr) | 2016-11-28 | 2021-06-30 | Aicuris Gmbh & Co Kg | Hemihidrat slobodne baze n-[5-(aminosulfonil)-4-metil-1,3-tiazol-2-il]-n-metil-2-[4-(2-piridinil)fenil]acetamida, postupci njegove proizvodnje i upotrebe |
CN110225781B (zh) | 2017-01-09 | 2022-05-17 | 辉诺生物医药科技(杭州)有限公司 | 噻唑衍生物及其应用 |
CN111433203B (zh) * | 2017-10-05 | 2024-02-13 | 创新分子股份有限公司 | 作为抗病毒化合物的取代噻唑的对映异构体 |
-
2018
- 2018-10-04 CN CN201880065255.2A patent/CN111433203B/zh active Active
- 2018-10-04 FI FIEP18779696.6T patent/FI3692039T3/fi active
- 2018-10-04 SG SG11202002420SA patent/SG11202002420SA/en unknown
- 2018-10-04 CA CA3077397A patent/CA3077397A1/en active Pending
- 2018-10-04 HR HRP20230158TT patent/HRP20230158T1/hr unknown
- 2018-10-04 AU AU2018344471A patent/AU2018344471B2/en active Active
- 2018-10-04 JO JOP/2020/0110A patent/JOP20200110A1/ar unknown
- 2018-10-04 UY UY0001037917A patent/UY37917A/es unknown
- 2018-10-04 TW TW107135101A patent/TWI706941B/zh active
- 2018-10-04 WO PCT/EP2018/077022 patent/WO2019068817A1/en active Application Filing
- 2018-10-04 PL PL18779696.6T patent/PL3692039T3/pl unknown
- 2018-10-04 DK DK18779696.6T patent/DK3692039T3/da active
- 2018-10-04 MX MX2020003369A patent/MX2020003369A/es unknown
- 2018-10-04 UA UAA202002635A patent/UA126163C2/uk unknown
- 2018-10-04 RS RS20230156A patent/RS64000B1/sr unknown
- 2018-10-04 US US16/753,814 patent/US11278534B2/en active Active
- 2018-10-04 JP JP2020519403A patent/JP7215689B2/ja active Active
- 2018-10-04 BR BR112020006710A patent/BR112020006710A2/pt unknown
- 2018-10-04 EA EA202090620A patent/EA202090620A1/ru unknown
- 2018-10-04 KR KR1020207009294A patent/KR20200066619A/ko not_active Application Discontinuation
- 2018-10-04 EP EP22213253.2A patent/EP4209491A1/en active Pending
- 2018-10-04 MA MA50609A patent/MA50609B1/fr unknown
- 2018-10-04 MD MDE20200816T patent/MD3692039T2/ro unknown
- 2018-10-04 SI SI201830861T patent/SI3692039T1/sl unknown
- 2018-10-04 AR ARP180102864A patent/AR113344A1/es unknown
- 2018-10-04 EP EP18779696.6A patent/EP3692039B1/en active Active
- 2018-10-04 HU HUE18779696A patent/HUE061307T2/hu unknown
- 2018-10-04 ES ES18779696T patent/ES2939652T3/es active Active
- 2018-10-04 LT LTEPPCT/EP2018/077022T patent/LT3692039T/lt unknown
- 2018-10-04 CR CR20200154A patent/CR20200154A/es unknown
- 2018-10-04 PT PT187796966T patent/PT3692039T/pt unknown
-
2020
- 2020-03-25 PH PH12020550132A patent/PH12020550132A1/en unknown
- 2020-03-29 IL IL273681A patent/IL273681A/en unknown
- 2020-04-01 NI NI202000025A patent/NI202000025A/es unknown
- 2020-04-01 CL CL2020000869A patent/CL2020000869A1/es unknown
- 2020-04-03 EC ECSENADI202021132A patent/ECSP20021132A/es unknown
- 2020-05-04 ZA ZA2020/02150A patent/ZA202002150B/en unknown
-
2022
- 2022-01-21 US US17/581,166 patent/US20220152008A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112020006710A2 (pt) | Enantiômeros de tiazóis substituídos como compostos antivirais | |
SV2018005792A (es) | Nuevos derivados piperidinilo sustituidos con hetero (arilo), un proceso para su preparacion y composiciones farmaceuticas que los contienen | |
BR112017028318A2 (pt) | compostos antibacterianos | |
BR112018076126A2 (pt) | compostos heterocíclicos como antibacterianos | |
BR112015024640A2 (pt) | processo para a preparação de um polímero antibacteriano, polímero antibacteriano, uso do polímero e produto antibacteriano | |
EP3533794A3 (de) | Materialien für elektronische vorrichtungen | |
BR112017008659A2 (pt) | ?métodos e compostos de agonista de gip? | |
EP3251868A4 (en) | Lithographic printing plate master, manufacturing method therefor, and printing method using same | |
BR112017013498A2 (pt) | composições de inibidor de nitrificação e métodos para a preparação das mesmas | |
BR112016007581A2 (pt) | pigmentos à base de compostos de bismuto | |
CO2018010689A2 (es) | Derivados de aminotiazol útiles como agentes antivíricos | |
BR112018003800A2 (pt) | derivados de 1,7-diaril-1,6-heptadieno-3,5-diona, processo para a sua produção e utilização | |
BR112017002662A2 (pt) | processo para preparar furfural e/ou derivados de furfural. | |
BR112016016461A8 (pt) | pigmentos baseados em compostos de bismuto, seu processo de preparação, seu uso e matriz de polímero que compreende pelo menos um pigmento | |
DK3374172T3 (da) | Presseværktøj, udformet som en presseplade | |
BR112018014401A2 (pt) | composições pulverizadas sólidas com substâncias ativas de superfície em carreadores solúveis em água sólidos, seu processo para a produção e uso das mesmas? | |
CL2016002677A1 (es) | Compuestos heteroaromáticos y su uso como ligandos de dopamina d1. | |
BR112017018993A2 (pt) | Processo para preparar 3-cloro-2- vinilfenilassulfonatos | |
BR112017007509A2 (pt) | Processo para a preparação de 1-(3,5-dicloro-4- fluoro-fenil)-2,2,2-trifluoro-etanona | |
BR112015017637A2 (pt) | compósito plano, processo para produção de um compósito plano, recipiente, processo para a produção de um recipiente e uso de um compósito ou de um recipiente | |
BR112016026684A2 (pt) | Fertilizante à base de enxofre | |
BR112016024831A2 (pt) | ?processo de produção de etanol celulósico integrado? | |
BR112017015298A2 (pt) | processo para a decomposição de material de biomassa contendo lignocelulose? | |
BR112016028693A2 (pt) | processo para preparação de 3-cloro-2-vinilfenol. | |
BR112015027707A2 (pt) | Método de preparação de derivados de 3,5-bis(fluoroalquil)pirazole e compostos intermediários envolvidos nesse método |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B12F | Other appeals [chapter 12.6 patent gazette] |
Free format text: RECURSO: 870210016539 - 19/02/2021 |
|
B06W | Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette] |